To test if rescue of gene expression after ASO treatment occurs in human MDS iNeurons, we performed bulk RNA-sequencing of both unaffected control and MDS iNeurons after fourteen days of ASO treatment at the two highest doses of both MECP2 ASOs (Fig. 4A). Here, MECP2 is linked to myelodysplastic syndrome.